"Cryolife: Complying with FDA Agreement Monday December 23, 2:07 pm ET
NEW YORK (Reuters) - CryoLife Inc. (NYSE:CRY - News), which last August recalled much of the human tissue it processes for transplants, "SAID on Monday IT BELIEVES" it is still complying with an agreement that allows it to keep processing and selling tissues while it improves safety procedures.
Even CRY is not sure of the outcome!! The problem here will be consumer and investor trust, this uncertainty makes CRY stock too volatile.
I'm bringing some points for everybodys analysis and comments. I have been on this stock and ride the up and downs. The only fact we know is the extension expiration of 1/15/03 and that CRY believes it is still in compliance.